Yuvraj_pawp, Author at Pharma Advancement

Micromeritics' Instrument Grant Committee has recently selected its latest grant recipient. A TriStar II Plus 3030, NanoPlus 3 and Flowprep...

G-CON Manufacturing Selected to Build Aseptic Formulation and Filling PODs for UTHSC

by Yuvraj_pawp

31st March 2015

G-CON Manufacturing has been selected to build a multi-POD ISO Class 7 Formulation and Filling Suite for the University of...

Micromeritics Announces Instrument Grant to the Massachusetts Institute of Technology

by Yuvraj_pawp

31st March 2015

Micromeritics' Instrument Grant Committee has recently selected its latest grant recipient. A 3Flex Surface Characterisation Analyser was awarded to the...

Ireland’s Horizon Pharma to buy Hyperion for $1.1bn

by Yuvraj_pawp

31st March 2015

Irish biopharmaceutical firm Horizon Pharma has signed an agreement to acquire US-based Hyperion Therapeutics for around $1.1bn. As part...

CHMP recommends new single-pill combination therapy to treat type 2 diabetes

by Yuvraj_pawp

30th March 2015

30 March 2015 The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended Boehringer...

GSK to provide meningitis B vaccine in UK

by Yuvraj_pawp

30th March 2015

GlaxoSmithKline (GSK) has entered an agreement with the UK's Department of Health to provide meningitis B vaccine for babies in...

Multisorb to Attend Interphex 2015

by Yuvraj_pawp

27th March 2015

Multisorb Technologies has announced it will be exhibiting at Interphex in New York. The event will take place from 20-22...

New Flavour Capabilities at RSSL

by Yuvraj_pawp

27th March 2015

Reading Scientific Services (RSSL) will launch a new suite of flavour services in April, which include sophisticated flavour analysis. Analysis...

GSK obtains Japanese approval for Encruse Ellipta to treat COPD

by Yuvraj_pawp

27th March 2015

GlaxoSmithKline (GSK) has obtained Japanese approval for its Encruse Ellipta (umeclidinium). The Japanese Ministry of Health, Labour and Welfare...

Signum out-licenses SIG990 to Dermata to develop new topical treatment for rosacea

by Yuvraj_pawp

26th March 2015

US-based biotechnology firm Signum Dermalogix has out-licensed SIG990, a new anti-inflammatory compound, to Dermata Therapeutics for the development of a...

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

Robots and AI in Drug Discovery Are Transforming Medicine

Stringent Policy around COVID Vaccines Laid by FDA

Pharmaceutical Chemicals Market Booms with Rising API Demand

Next in Pharma 2025: Innovations Shaping the Future

Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

AI Revolutionizing Drug Discovery and Clinical Development

China’s Super Me-Too Drug Development: A New Pharma Frontier

Asia Pacific Omics-Based Clinical Trials Market Growth

Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

Robots and AI in Drug Discovery Are Transforming Medicine

Stringent Policy around COVID Vaccines Laid by FDA

Pharmaceutical Chemicals Market Booms with Rising API Demand

Next in Pharma 2025: Innovations Shaping the Future

Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

AI Revolutionizing Drug Discovery and Clinical Development

China’s Super Me-Too Drug Development: A New Pharma Frontier

Asia Pacific Omics-Based Clinical Trials Market Growth

Yuvraj_pawp

Micromeritics Announces Instrument Grant to the University of Georgia

G-CON Manufacturing Selected to Build Aseptic Formulation and Filling PODs for UTHSC

Micromeritics Announces Instrument Grant to the Massachusetts Institute of Technology

Ireland’s Horizon Pharma to buy Hyperion for $1.1bn

CHMP recommends new single-pill combination therapy to treat type 2 diabetes

GSK to provide meningitis B vaccine in UK

Multisorb to Attend Interphex 2015

New Flavour Capabilities at RSSL

GSK obtains Japanese approval for Encruse Ellipta to treat COPD

Signum out-licenses SIG990 to Dermata to develop new topical treatment for rosacea

Qucik Links

About Us

Subscribe Us

System

Resources

Retrieve your password